- Global Pharma News & Resources

Antibiotics Market To Reach USD 63.34 Billion By 2026 | CAGR of 3.5% |Bristol-Myers Squibb Co, AstraZeneca plc, The Menarini Group

: New York, United States, 28-July-2020, (Via WiredRelease), (Reports and Data) – The Antibiotics Market is estimated to reach USD 63.34 Billion by 2026, according to a new report by Reports and Data. This can be mainly associated with the growing incidences of infectious diseases such as pneumonia, HIV/AIDS, malaria, and tuberculosis along with technological advancements that are expected to become the most common growth factors globally in the coming years.

Expanding efforts initiated by the key companies for the development of advanced products will boost market growth. A report by the Pew Charitable Trust states, about 37 promising molecules were investigated within the U.S. market in March 2016. Majority of which are in clinical trials phase II and are expected to hit the market in the coming years. Moreover, supportive government enactments, such as the GAIN (Generating Antibiotics Incentives Now) Act, is anticipated to facilitate the approval process. GAIN Act has plans, which promote the advancement of therapies against antibiotic-resistant pathogens. Diarrhea is one of the leading causes of death among children across the globe, and it requires antibiotic mediation to reduce the death rate. Other infectious diseases that may boost the growth of the market are pneumonia, HIV/AIDS, malaria, and tuberculosis. Moreover, the development of new infections, such as the Ebola virus and Zika, are also promoting the development and growth of the antibiotics market.

Get Sample Copy with TOC of the Report to understand the structure of the complete report @

The COVID-19 impact:
Covid-19’s spread has affected manufacturing and construction activities worldwide. Logistic limitations and reconsiderations of the raw material requirements are becoming a problem for producers. The producers have relied on derived demand as an intermediate commodity to rationalize production. The pandemic’s economic impact on companies and financial markets is also not favorable. Stock market volatility and decreasing global growth are anticipated, which will affect the market.  The market has experienced a downturn over the weeks, which may continue over the next few months. The Asia Pacific is the most affected region by this pandemic, with China at the center of the outbreak. Most initiatives in multiple countries have changed to a temporary halt. Development, as well as supply, is put on hold, creating losses for suppliers, dealers and customers alike.

Key participants include

Bristol-Myers Squibb Co., AstraZeneca plc, The Menarini Group, GlaxoSmithKline plc, Bayer HealthCare AG, Eli Lilly and Company, Merck & Co., Inc., Johnson & Johnson, Novartis AG, Teva Pharmaceutical Industries Ltd., Sanofi.

Get Discount on the report @

For the purpose of this report, Reports and Data have segmented into the global Antibiotics market on the basis of type, propellants, application, and region:

By Type Outlook (Revenue, USD Million; 2016-2026)

RNA Synthesis InhibitorsDNA Synthesis InhibitorsCell Wall Synthesis InhibitorsProtein Synthesis InhibitorsMycolic Acid Inhibitors

By End-User Outlook (Revenue, USD Million; 2016-2026)

Retail pharmaciesOnline pharmaciesHospital pharmacies

Product Outlook (Revenue, USD Million; 2016-2026)


Regional Outlook (Revenue, USD Million; 2017-2027)

North America





Asia Pacific





Latin America


Purchase this report @ 

Key aspects of the Antibiotics Market Report:

The report comprises of Antibiotics market overview, market share, demand and supply ratio, supply chain analysis, and import/export details.

The report explores different strategies and procedures undertaken by key market players that assist in making profitable decisions.

The report covers all the crucial information about the products and services of major competitors.

About Us:
Our in-house experts assist our clients with advice based on their proficiency in the market that helps them in creating a compendious database for the clients. Our team offers expert insights to clients to guide them through their business ventures. We put in rigorous efforts to keep our clientele satisfied and focus on fulfilling their demands to make sure that the end-product is what they desire. We excel in diverse fields of the market and with our services extending to competitive analysis, research and development analysis, and demand estimation among others, we can help you invest your funds in the most beneficial areas for research and development.

Contact Us:
John Watson
Head of Business Development
Reports and Data | Web:
Direct Line: +1-212-710-1370

This content has been published by MARKETYSERS GLOBAL CONSULTING LLP company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 28-Jul-2020